NLS Pharmaceutics AG logo

NLS Pharmaceutics AG NLSP

Quarterly report 2025-Q4
added 05-27-2026

report update icon

Country

schweizSchweiz

IPO year

2021

Industry

-

Stock Exchange

NASDAQ GLOBAL

Shares

3.84 M

Market Cap[1]

$ 1.62 M

EBITDA (LTM)

$ -8.41 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

1.6

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.